These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 30284486)

  • 1. Design, synthesis and biological evaluation of tricyclic pyrazolo[1,5-c][1,3]benzoxazin-5(5H)-one scaffolds as selective BuChE inhibitors.
    Qiu GL; He SS; Chen SC; Li B; Wu HH; Zhang J; Tang WJ
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1506-1515. PubMed ID: 30284486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors.
    Chen SC; Qiu GL; Li B; Shi JB; Liu XH; Tang WJ
    Eur J Med Chem; 2018 Mar; 147():194-204. PubMed ID: 29438888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
    Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
    Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel structural hybrids of pyrazolobenzothiazines with benzimidazoles as cholinesterase inhibitors.
    Aslam S; Zaib S; Ahmad M; Gardiner JM; Ahmad A; Hameed A; Furtmann N; Gütschow M; Bajorath J; Iqbal J
    Eur J Med Chem; 2014 May; 78():106-17. PubMed ID: 24681070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of δ-sultone-fused pyrazoles for treating Alzheimer's disease: Design, synthesis, biological evaluation and SAR studies.
    Xu Y; Zhang Z; Jiang X; Chen X; Wang Z; Alsulami H; Qin HL; Tang W
    Eur J Med Chem; 2019 Nov; 181():111598. PubMed ID: 31415981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer's disease: Design, synthesis, biological evaluation, and docking study.
    Mollazadeh M; Mohammadi-Khanaposhtani M; Zonouzi A; Nadri H; Najafi Z; Larijani B; Mahdavi M
    Bioorg Chem; 2019 Jun; 87():506-515. PubMed ID: 30928873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure-based optimization of δ-sultone-fused pyrazoles as selective BuChE inhibitors.
    Zhang Z; Min J; Chen M; Jiang X; Xu Y; Qin H; Tang W
    Eur J Med Chem; 2020 Sep; 201():112273. PubMed ID: 32569925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, facile synthesis, and evaluation of novel spiro- and pyrazolo[1,5-c]quinazolines as cholinesterase inhibitors: Molecular docking and MM/GBSA studies.
    Gálvez J; Polo S; Insuasty B; Gutiérrez M; Cáceres D; Alzate-Morales JH; De-la-Torre P; Quiroga J
    Comput Biol Chem; 2018 Jun; 74():218-229. PubMed ID: 29655025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
    Zha GF; Zhang CP; Qin HL; Jantan I; Sher M; Amjad MW; Hussain MA; Hussain Z; Bukhari SN
    Bioorg Med Chem; 2016 May; 24(10):2352-9. PubMed ID: 27083471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel N-benzylpiperidine derivatives of 5-arylisoxazole-3-carboxamides as anti-Alzheimer's agents.
    Saeedi M; Felegari P; Iraji A; Hariri R; Rastegari A; Mirfazli SS; Edraki N; Firuzi O; Mahdavi M; Akbarzadeh T
    Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000258. PubMed ID: 33226157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
    Pourabdi L; Khoobi M; Nadri H; Moradi A; Moghadam FH; Emami S; Mojtahedi MM; Haririan I; Forootanfar H; Ameri A; Foroumadi A; Shafiee A
    Eur J Med Chem; 2016 Nov; 123():298-308. PubMed ID: 27484515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and cholinesterase inhibition assay of liquiritigenin derivatives as anti-Alzheimer's activity.
    Guan L; Peng D; Zhang L; Jia J; Jiang H
    Bioorg Med Chem Lett; 2021 Nov; 52():128306. PubMed ID: 34371131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
    Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
    Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
    Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
    Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of acridone glycosides as selective BChE inhibitors.
    Ma W; Bi J; Zhao C; Gao Y; Zhang G
    Carbohydr Res; 2020 May; 491():107977. PubMed ID: 32169593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, biological evaluation and docking study of 5-oxo-4,5-dihydropyrano[3,2-c]chromene derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Khoobi M; Alipour M; Sakhteman A; Nadri H; Moradi A; Ghandi M; Emami S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2013 Oct; 68():260-9. PubMed ID: 23988409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives.
    Alipour M; Khoobi M; Moradi A; Nadri H; Homayouni Moghadam F; Emami S; Hasanpour Z; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Jul; 82():536-44. PubMed ID: 24941128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cinnamic acid-tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Ghafary S; Najafi Z; Mohammadi-Khanaposhtani M; Nadri H; Edraki N; Ayashi N; Larijani B; Amini M; Mahdavi M
    Arch Pharm (Weinheim); 2018 Oct; 351(10):e1800115. PubMed ID: 30284339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.